1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd end, revised. American Psychiatric Association, Washington, DC, pp 103?107
2. Becker RE, Giacobini E (1988) Mechanism of cholinesterase inhibitions in senile dementia of the Alzheimer type: clinical, pharmacological and therapeutic aspects. Drug Dev Res 12:163?195
3. Brodaty H, Gresham M (1989) Effects of a training programme to reduce stress in carers of patients with dementia. Br Med J 299:1375?1379
4. Chatellier G, Lacomblez L (1990) Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Br Med J 300:495?499
5. Gamzu ER, Thal LJ, Davis KL (1989) Therapeutic trials using tacrine and other cholinesterase inhibitors. In: Wurtmann RJ, Corkin S, Growdon JHA, Ritter-Walkes E (eds) Alzheimer's disease. Proceedings of the Fifth Meeting of the International Group on the Pharmacology of Memory Disorders Associated with Aging, Zurich 1989 Center for Brain Sciences and Metabolism, Cambridge, Massachusetts, pp 379?386